GREY WOLF THERAPEUTICS LIMITED
Company number 10989365 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£86,763,972
Balance sheet as at 2024-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2017-09-29
- Employees
- 19 (2024 accounts · was 18 in 2023)
- Registered office
- 99 Park Drive, Milton, Abingdon, England, OX14 4RY
- Postcode
- OX14 4RY
- Capital
- 3 GBP
- Accounts category
- Small
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-10-27
- Next due by
- 2026-11-10
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 11 current · 5 resigned
Group structure
Controlled by Biodiscovery 5 Fpci (GP02029) — since 2019-02-12
From persons-with-significant-control filings on the public register.
Contact details
- Website
- greywolftherapeutics.com
- Phone
- +44 1235644970
Novel antigen modulation technology that controls T cells to guide the immune system
Among its peers
Top 5%
by shareholders' funds, of 179 similar companies in OX
Among the biggest employers among its local peers (19 staff).
Trading since 2017.
No.2 of the largest research and experimental development on biotechnology companies in Oxford →
Competitors Oxford
This company ranks 2 among research and experimental development on biotechnology in Oxford.
The class of 2017
37%
of the 435 companies in this sector incorporated in 2017 are still active today; 61% have since been dissolved.
A fact about the year, not a forecast for this company.